Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Temozolomide (TMZ) and dacarbazine (DTIC) are alkylating agents (ALK) with antitumor efficacy in metastatic PanNET. Rechallenging ALK following prior efficacy is commonly performed but has not been evaluated.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: De Rycke O, Walter T, Perrier M, Hentic O, Lombard-Bohas C,
Keywords: alkylating agents, pancreatic NET, re-challenge, chemotherapy,
Introduction: A new syringe (NS) for the delivery of lanreotide autogel was approved in Oct 2018 in France. The NS includes updated features (larger flanges, more robust plunger) intended to ease the injection.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Walter T, Eskenazi M, Rama N, Gueguen D, Mir O,
Keywords: neuroendocrine tumors, lanreotide, nursing, patient-reported outcomes,
Introduction: Rectal neuroendocrine carcinomas (NEC) are extremely rare and account for less than 1% of colorectal malignancies.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Della Torre S
Authors: Lombardi P, Grandi S, Marinelli M, Manara M, Della Torre S,
Keywords: rectal nec, net, chemotherapy, metastatic disease,
Introduction: Pancreatic neuroendocrine tumors (pNETs) in patients with Multiple Endocrine Neoplasia Syndrome type 1 (MEN 1) are frequently multiple and occur with an incidence that varies from 30-80% in different series. Magnetic Resonance Imaging (MRI) and techniques such as endoscopic ultrasound (EUS) are useful tools for tumor localization, size assessment and follow-up.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Tsoli M, Alexandraki K, Angelousi A, Karoumpalis I, Kolomodi D,
Keywords: pancreatic, neuroendocrine, MEN1, MRI, EUS,
#2201 Early Prognostic Factors in Medullary Thyroid Carcinoma
Introduction: Medullary thyroid carcinoma (MTC) prognosis has been related with several variables, being calcitonin doubling time one of the most important prognostic factor. However, it is not evaluable in the early postoperative period.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Muñoz de Nova J, Di Martino M, Marín Campos C, Lahera Vargas M, Mora Guzmán I,
Keywords: medullary thyroid carcinoma, thyroid surgery, prognosis,